Latest News
& Press Releases

Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.

TOP STORIES
Sinovac’s CoronaVac was the first COVID-19 vaccine approved in China for emergency use back in June 2020.
Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The vaccine demonstrated efficacy in mild, moderate, and severe COVID-19 of 77.8% with efficacy against severe disease of 93.4%.
Startups have passion and big, bold ideas. Pharma has the funds and human resources. Together, they can change the future of medicine.
For the first time in an organ-on-a-chip model, the live SARS-CoV-2 virus has successfully infected and replicated in human tissue.
The two were charged with conspiracy to commit trade secret theft and wire fraud, international money laundering and obstruction of justice.
Following a manufacturing mistake that left Emergent BioSolutions with a botched batch of Johnson & Johnson’s COVID-19 vaccine, Emergent is now facing a shareholder lawsuit accusing the company of insider trading.
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
University of Oxford researchers have begun clinical trials for a new vaccine that can potentially target a wide range of HIV variants.
Two life sciences companies from two very different areas of medicine announced launches today. Here’s a look.
The WHO is calling for manufacturers to cut prices and increase the availability of supplies to low- and middle-income nations to parts of the world where COVID-19 continues to surge.
UPCOMING EVENTS
PRESS RELEASES
MARKET RESEARCH REPORTS